Skip to main content
. 2022 May 21;111:135–147. doi: 10.1016/j.reprotox.2022.05.012

Fig. 2.

Fig. 2

Adverse effects of remdesivir (RDV) on the expansion and maintenance of the blastocyst cavity. Embryos are treated with indicated concentrations of RDV from E2.5 to E4.5. A. Representative images of RDV-treated embryos at E2.5 (before treatment), E3.5, and E4.5. Scale bar = 100 µm. B. The size of RDV-treated embryos. Different letters indicate statistically significant differences among treatments (mean ± 95% CI, n = 27 or 28 for each treatment group, one-way ANOVA followed by t-test, p < 0.01). No significant difference is observed among treatments at E3.5.